269 related articles for article (PubMed ID: 6356900)
1. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
Frishman WH; Michelson EL; Johnson BF; Poland MP
Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
[TBL] [Abstract][Full Text] [Related]
2. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
3. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
[TBL] [Abstract][Full Text] [Related]
4. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
8. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
9. On the combination of alpha- and beta-adrenoceptor blockade in hypertension.
Stokes GS; Mennie BA; Gellatly R; Hill A
Clin Pharmacol Ther; 1983 Nov; 34(5):576-82. PubMed ID: 6627819
[TBL] [Abstract][Full Text] [Related]
10. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
13. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
Kubik MM; Coote JH
Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
[TBL] [Abstract][Full Text] [Related]
14. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy with labetalol compared with propranolol. Differential effects by race.
Flamenbaum W; Weber MA; McMahon FG; Materson BJ; Carr AA; Poland M
J Clin Hypertens; 1985 Mar; 1(1):56-69. PubMed ID: 3915317
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
Wallin JD; Wilson D; Winer N; Maronde RF; Michelson EL; Langford H; Maloy J; Poland M
Am J Med; 1983 Oct; 75(4A):87-94. PubMed ID: 6356903
[TBL] [Abstract][Full Text] [Related]
17. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
[TBL] [Abstract][Full Text] [Related]
18. Labetalol in essential hypertension.
Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
[TBL] [Abstract][Full Text] [Related]
19. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
Weidler DJ; Vidt DG; Toth PD; Due DL; Sirgo MA
J Clin Pharmacol; 1990 Jun; 30(6):524-32. PubMed ID: 2355103
[TBL] [Abstract][Full Text] [Related]
20. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
